---
title: "Experimental Plan"
author: "Callum Malcolm"
date: "2023-12-07"
output: pdf_document
toc: true
toc_float: true
urlcolor: blue

---

\newpage

# Project 1: Modelling the BL Tumour Microenviroment

## Overview
- Using A20 to model BL immune TME
  * Look specifically at T-cell infiltration
  * Immune evasion mechanisms deployed by BL 
- Compare results to patient data
- Apply findings to humanised mouse models of BL PDX

## Background
- The impact of immune TME in BL is unclear
- BL 

## Experimental Plan

### E1: NSG vs BALB/C A20 injection
#### E1 Overview
- Compare between immunocompetent and immunocomprimised mice
- Basic actors to compare
  * Tumour growth rate
  * Tumour size
  
#### IHC Panel
- Compare markers between tumour types
- Burkitt IHC indentification:
  * CD10+ (B-Cell Germinal Centre)
  * Bcl-2-
  * Ki-67%hi (proliferation index)
  
  Potential IHC Panel Markers
  
| Cell Type | Marker | 
| :-------: | :------: | 
| Proliferation marker | Ki67 |
| B cell | CD20 |
|   T cells (all)   | CD3 |
| T Cells (cytotoxic) | CD8 |
| T cells (helper) | CD 4 |
| Dendritic Cells | CD11c |
| Macrophage | F4/80 |

#### Flow Panel
- Options are:
  * Standard T Cell
  * TRegs
  * B-cells
  * DC Mono CD11c
  * Th17
  * TfH
  
 Standard T Cell
  
| Cell Type | Marker | 
| :-------: | :------: | 
| T Memory | CXCR3 |
| Naive Immune Cells | CCR7 |
|   Naive T Cells   | CD45RA |
| Th17 | CCR6 |
| GC B-Cells | CD38 |
| TRegs (Helper) | CD4 |
| Macrophage | HLA-DR |
|  T Cells (all)   | CD3 |
| T Cells (Cytoxic)  | CD8 |




